Frontier Medicines

Frontier Medicines company information, Employees & Contact Information

Frontier Medicines, located in South San Francisco, CA and Boston, MA, is a precision medicine company that has pioneered a powerful discovery and development platform designed to generate medicines against disease-causing proteins previously considered undruggable. We are deploying our technologies in chemoproteomics, covalent drug discovery, and machine learning to develop a pipeline of groundbreaking medicines against the most important drivers of disease. Our lead program targets both the activated and inactive forms of KRAS G12C, a validated driver in a number of cancers that until recently has been undruggable. Our pipeline embodies our vision of bolding advancing science to defeat disease, starting with cancer.

Company Details

Employees
84
Founded
-
Address
South San Francisco, Ca 94080, Us
Phone
650 457 1005
Email
co****@****eds.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
South San Francisco, CA
Looking for a particular Frontier Medicines employee's phone or email?

Frontier Medicines Questions

News

Frontier Medicines Presents Preclinical Data from Three Programs at the 37th AACR-NCI-EORTC International Conference on Molecular Targets - Yahoo Finance

Frontier Medicines Presents Preclinical Data from Three Programs at the 37th AACR-NCI-EORTC International Conference on Molecular Targets Yahoo Finance

Frontier Medicines and AbbVie Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets - Investing News Network

Frontier Medicines and AbbVie Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets Investing News Network

Frontier Medicines Appoints Seasoned Executive Gregory Chow as Chief Financial Officer - PR Newswire

Frontier Medicines Appoints Seasoned Executive Gregory Chow as Chief Financial Officer PR Newswire

Frontier Medicines Announces Third Precision Oncology Development Candidate - Yahoo Finance

Frontier Medicines Announces Third Precision Oncology Development Candidate Yahoo Finance

Frontier Medicines Announces Publication in Structure Highlighting Novel E3 Ligase DCAF2 can be Harnessed for Targeted Protein Degradation - The Manila Times

Frontier Medicines Announces Publication in Structure Highlighting Novel E3 Ligase DCAF2 can be Harnessed for Targeted Protein Degradation The Manila Times

Frontier Medicines launches with $67 million to develop novel medicines that drug the "undruggable" targets driving human disease - PR Newswire

Frontier Medicines launches with $67 million to develop novel medicines that drug the "undruggable" targets driving human disease PR Newswire

Frontier Medicines Appoints Gerardo Ubaghs as Chief Financial Officer and Announces $20 Million Series C Extension - Yahoo Finance

Frontier Medicines Appoints Gerardo Ubaghs as Chief Financial Officer and Announces $20 Million Series C Extension Yahoo Finance

Frontier Medicines Announces FMC-220, the First Covalent p53 Y220C Activator Development Candidate, with Best-in-Class Potential - The Manila Times

Frontier Medicines Announces FMC-220, the First Covalent p53 Y220C Activator Development Candidate, with Best-in-Class Potential The Manila Times

Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline - Yahoo Finance

Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline Yahoo Finance

Top Frontier Medicines Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant